David Reardon, MD | Authors

Articles

Rindopepimut for Recurrent Glioblastoma

November 17, 2014

David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, president, Society for Neuro-Oncology, describes the mechanism of action of rindopepimut for recurrent glioblastoma.